EU‑GMP medical cannabis for Europe, controlled end to end at source.
Mavari Medical GmbH is establishing a licensed pharmaceutical importer and wholesaler in Lower Saxony. We are currently applying for our Wholesale Distribution Authorisation (WDA) and Manufacturing and Import Authorisation (MIA), and building an experienced team to bring single‑estate, EU‑GMP medicinal cannabis to pharmacies across Germany and Europe.
WDA and MIA applications under way
Applications in progress with the competent authority in Lower Saxony, supported by an established German regulatory partner and a GDP‑compliant logistics network.
Single estate. Controlled at source.
Part of the Mavari Group, with cultivation under a single estate — every batch grown, tested and released to one standard, from plant to pharmacy.
Built to EU‑GMP from day one
A pharmaceutical quality system, Qualified Person release and independent EU laboratory testing — designed around the requirements of German pharmacies and wholesalers.
We are building an experienced team in Germany.
Licensing, quality and supply are led by people who have done this before in regulated pharmaceutical environments. As our applications progress we are appointing the statutory roles below and the commercial team around them.
If you have EU‑GMP or GDP experience — in medicinal cannabis or wider pharma — and would like to be part of it, we would like to hear from you.
Get in touchPharmacies, wholesalers and partners are welcome to contact us ahead of launch.